Remove the obstacle and get into the flow

Key Points Patients with classical and paradoxical low‐flow (PLF) aortic stenosis (AS) experience similar improvements in 30‐day quality of life (QoL) following transcatheter aortic valve replacement (TAVR) as compared to those with normal flow AS. Particular care should be taken in post‐TAVR manage...

Full description

Saved in:
Bibliographic Details
Published in:Catheterization and cardiovascular interventions 2020-10, Vol.96 (4), p.979-980
Main Authors: Aranzulla, Tiziana Claudia, Musumeci, Giuseppe
Format: Article
Language:English
Subjects:
Aortic Valve Stenosis
Biomechanical Phenomena
Humans
Quality of Life
Transcatheter Aortic Valve Replacement
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3136-b3bd36ef5fe0141aa60b40ff2bfb71d4e679bd5c3eb1cbe931a32f07633bc1d33
container_end_page 980
container_issue 4
container_start_page 979
container_title Catheterization and cardiovascular interventions
container_volume 96
creator Aranzulla, Tiziana Claudia
Musumeci, Giuseppe
description Key Points Patients with classical and paradoxical low‐flow (PLF) aortic stenosis (AS) experience similar improvements in 30‐day quality of life (QoL) following transcatheter aortic valve replacement (TAVR) as compared to those with normal flow AS. Particular care should be taken in post‐TAVR management of patients with PLF AS due to a higher rate of rehospitalization for heart failure. Promoting larger studies with follow‐up strategies that take into account the initial echocardiographic AS phenotype may help in further improving post‐TAVR QoL and outcomes.
doi_str_mv 10.1002/ccd.29296
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2452976815</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2452329146</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3136-b3bd36ef5fe0141aa60b40ff2bfb71d4e679bd5c3eb1cbe931a32f07633bc1d33</originalsourceid><addsrcrecordid>eNp10MtKw0AUBuBBFFurC19AAm7sIu1ckklnKfEKgiAK7oa5nNGUJFMziaVvb2yqC8HVOXA-fg4_QqcEzwjGdG6MnVFBBd9DY5JSGmeUv-7vdiISPkJHISwxxoJTcYhGjOFFSgQfo-kTVP4TovYdIq9Dq0wJkapt9AZtVNSt315c6dfH6MCpMsDJbk7Qy831c34XPzze3ueXD7FhhPFYM20ZB5c6wCQhSnGsE-wc1U5nxCbAM6FtahhoYjQIRhSjDmecMW2IZWyCLobcVeM_OgitrIpgoCxVDb4LkiYpFRlfkLSn53_o0ndN3X-3VYwKkvBeTQdlGh9CA06umqJSzUYSLL_7k31_cttfb892iZ2uwP7Kn8J6MB_Auihh83-SzPOrIfILt-x3Yw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2452329146</pqid></control><display><type>article</type><title>Remove the obstacle and get into the flow</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Aranzulla, Tiziana Claudia ; Musumeci, Giuseppe</creator><creatorcontrib>Aranzulla, Tiziana Claudia ; Musumeci, Giuseppe</creatorcontrib><description>Key Points Patients with classical and paradoxical low‐flow (PLF) aortic stenosis (AS) experience similar improvements in 30‐day quality of life (QoL) following transcatheter aortic valve replacement (TAVR) as compared to those with normal flow AS. Particular care should be taken in post‐TAVR management of patients with PLF AS due to a higher rate of rehospitalization for heart failure. Promoting larger studies with follow‐up strategies that take into account the initial echocardiographic AS phenotype may help in further improving post‐TAVR QoL and outcomes.</description><identifier>ISSN: 1522-1946</identifier><identifier>EISSN: 1522-726X</identifier><identifier>DOI: 10.1002/ccd.29296</identifier><identifier>PMID: 33085196</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Aortic Valve Stenosis ; Biomechanical Phenomena ; Humans ; Quality of Life ; Transcatheter Aortic Valve Replacement ; Treatment Outcome</subject><ispartof>Catheterization and cardiovascular interventions, 2020-10, Vol.96 (4), p.979-980</ispartof><rights>2020 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3136-b3bd36ef5fe0141aa60b40ff2bfb71d4e679bd5c3eb1cbe931a32f07633bc1d33</cites><orcidid>0000-0002-5880-8278 ; 0000-0002-0306-1699</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33085196$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aranzulla, Tiziana Claudia</creatorcontrib><creatorcontrib>Musumeci, Giuseppe</creatorcontrib><title>Remove the obstacle and get into the flow</title><title>Catheterization and cardiovascular interventions</title><addtitle>Catheter Cardiovasc Interv</addtitle><description>Key Points Patients with classical and paradoxical low‐flow (PLF) aortic stenosis (AS) experience similar improvements in 30‐day quality of life (QoL) following transcatheter aortic valve replacement (TAVR) as compared to those with normal flow AS. Particular care should be taken in post‐TAVR management of patients with PLF AS due to a higher rate of rehospitalization for heart failure. Promoting larger studies with follow‐up strategies that take into account the initial echocardiographic AS phenotype may help in further improving post‐TAVR QoL and outcomes.</description><subject>Aortic Valve Stenosis</subject><subject>Biomechanical Phenomena</subject><subject>Humans</subject><subject>Quality of Life</subject><subject>Transcatheter Aortic Valve Replacement</subject><subject>Treatment Outcome</subject><issn>1522-1946</issn><issn>1522-726X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp10MtKw0AUBuBBFFurC19AAm7sIu1ckklnKfEKgiAK7oa5nNGUJFMziaVvb2yqC8HVOXA-fg4_QqcEzwjGdG6MnVFBBd9DY5JSGmeUv-7vdiISPkJHISwxxoJTcYhGjOFFSgQfo-kTVP4TovYdIq9Dq0wJkapt9AZtVNSt315c6dfH6MCpMsDJbk7Qy831c34XPzze3ueXD7FhhPFYM20ZB5c6wCQhSnGsE-wc1U5nxCbAM6FtahhoYjQIRhSjDmecMW2IZWyCLobcVeM_OgitrIpgoCxVDb4LkiYpFRlfkLSn53_o0ndN3X-3VYwKkvBeTQdlGh9CA06umqJSzUYSLL_7k31_cttfb892iZ2uwP7Kn8J6MB_Auihh83-SzPOrIfILt-x3Yw</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Aranzulla, Tiziana Claudia</creator><creator>Musumeci, Giuseppe</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5880-8278</orcidid><orcidid>https://orcid.org/0000-0002-0306-1699</orcidid></search><sort><creationdate>20201001</creationdate><title>Remove the obstacle and get into the flow</title><author>Aranzulla, Tiziana Claudia ; Musumeci, Giuseppe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3136-b3bd36ef5fe0141aa60b40ff2bfb71d4e679bd5c3eb1cbe931a32f07633bc1d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aortic Valve Stenosis</topic><topic>Biomechanical Phenomena</topic><topic>Humans</topic><topic>Quality of Life</topic><topic>Transcatheter Aortic Valve Replacement</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aranzulla, Tiziana Claudia</creatorcontrib><creatorcontrib>Musumeci, Giuseppe</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Catheterization and cardiovascular interventions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aranzulla, Tiziana Claudia</au><au>Musumeci, Giuseppe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Remove the obstacle and get into the flow</atitle><jtitle>Catheterization and cardiovascular interventions</jtitle><addtitle>Catheter Cardiovasc Interv</addtitle><date>2020-10-01</date><risdate>2020</risdate><volume>96</volume><issue>4</issue><spage>979</spage><epage>980</epage><pages>979-980</pages><issn>1522-1946</issn><eissn>1522-726X</eissn><abstract>Key Points Patients with classical and paradoxical low‐flow (PLF) aortic stenosis (AS) experience similar improvements in 30‐day quality of life (QoL) following transcatheter aortic valve replacement (TAVR) as compared to those with normal flow AS. Particular care should be taken in post‐TAVR management of patients with PLF AS due to a higher rate of rehospitalization for heart failure. Promoting larger studies with follow‐up strategies that take into account the initial echocardiographic AS phenotype may help in further improving post‐TAVR QoL and outcomes.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>33085196</pmid><doi>10.1002/ccd.29296</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-5880-8278</orcidid><orcidid>https://orcid.org/0000-0002-0306-1699</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1522-1946
ispartof Catheterization and cardiovascular interventions, 2020-10, Vol.96 (4), p.979-980
issn 1522-1946
1522-726X
language eng
recordid cdi_proquest_miscellaneous_2452976815
source Wiley-Blackwell Read & Publish Collection
subjects Aortic Valve Stenosis
Biomechanical Phenomena
Humans
Quality of Life
Transcatheter Aortic Valve Replacement
Treatment Outcome
title Remove the obstacle and get into the flow
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T10%3A44%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Remove%20the%20obstacle%20and%20get%20into%20the%20flow&rft.jtitle=Catheterization%20and%20cardiovascular%20interventions&rft.au=Aranzulla,%20Tiziana%20Claudia&rft.date=2020-10-01&rft.volume=96&rft.issue=4&rft.spage=979&rft.epage=980&rft.pages=979-980&rft.issn=1522-1946&rft.eissn=1522-726X&rft_id=info:doi/10.1002/ccd.29296&rft_dat=%3Cproquest_cross%3E2452329146%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3136-b3bd36ef5fe0141aa60b40ff2bfb71d4e679bd5c3eb1cbe931a32f07633bc1d33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2452329146&rft_id=info:pmid/33085196&rfr_iscdi=true